Pro-Dex, Inc. operates in the Surgical and medical instruments sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Pro-Dex with three other
companies in this sector in the United States:
Alliqua Biomedical Inc
sales of $18.24 million
Sonoma Pharmaceuticals Inc
of which 100%
was Drugs & Devices), and
CAS Medical Systems, Inc.
of which 81%
was Tisssue Oximetry Monitoring).
Pro-Dex reported sales of $20.16 million
June of 2016.
increase of 50.6%
versus 2015, when the company's sales were $13.38 million.